{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:22:52Z","timestamp":1793852572942,"version":"4.6.1"},"reference-count":105,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Tubeimoside-1 (TBMS-1), a natural triterpenoid saponin found in traditional Chinese herbal medicine Bolbostemmatis Rhizoma, is present in numerous Chinese medicine preparations. This review aims to comprehensively describe the pharmacology, pharmacokinetics, toxicity and targeting preparations of TBMS-1, as well the therapeutic potential for cancer treatement. Information concerning TBMS-1 was systematically collected from the authoritative internet database of PubMed, Web of Science, and China National Knowledge Infrastructure applying a combination of keywords involving \u201ctumor,\u201d \u201cpharmacokinetics,\u201d \u201ctoxicology,\u201d and targeting preparations. New evidence shows that TBMS-1 possesses a remarkable inhibitory effect on the tumors of the respiratory system, digestive system, nervous system, genital system as well as other systems <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>. Pharmacokinetic studies reveal that TBMS-1 is extensively distributed in various tissues and prone to degradation by the gastrointestinal tract after oral administration, causing a decrease in bioavailability. Meanwhile, several lines of evidence have shown that TBMS-1 may cause adverse and toxic effects at high doses. The development of liver-targeting and lung-targeting preparations can reduce the toxic effect of TBMS-1 and increase its efficacy. In summary, TBMS-1 can effectively control tumor treatment. However, additional research is necessary to investigate <jats:italic>in vivo<\/jats:italic> antitumor effects and the pharmacokinetics of TBMS-1. In addition, to reduce the toxicity of TBMS-1, future research should aim to modify its structure, formulate targeting preparations or combinations with other drugs.<\/jats:p>","DOI":"10.3389\/fphar.2022.941270","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T11:48:49Z","timestamp":1657885729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations"],"prefix":"10.3389","volume":"13","author":[{"given":"Chang-Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Zhou","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Qiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.drup.2017.05.002","article-title":"Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance","volume":"31","author":"Bar-Zeev","year":"2017","journal-title":"Drug resist. updat."},{"key":"B2","first-page":"12517","article-title":"Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt\/\u03b2-catenin signaling pathway.","volume":"8","author":"Bian","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S5-S16","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: Worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/cells8080774","article-title":"Tubeimoside-1 inhibits glioblastoma growth, migration, and invasion via inducing ubiquitylation of MET.","volume":"8","author":"Cao","year":"2019","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3892\/mmr.2020.11224","article-title":"Tubeimoside1 induces apoptosis in human glioma U251 cells by suppressing PI3K\/Aktmediated signaling pathways","volume":"22","author":"Cao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"9074893","DOI":"10.1155\/2018\/9074893","article-title":"Pharmacokinetics and bioavailability study of Tubeimoside I in ICR mice by UPLC-MS\/MS","volume":"2018","author":"Chen","year":"2018","journal-title":"J. Anal. Methods Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3892\/ijo.2011.1218","article-title":"Tubeimoside-1 induces G2\/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca2+ and caspase-dependent signaling pathways","volume":"40","author":"Chen","year":"2012","journal-title":"Int. J. Oncol."},{"key":"B8","first-page":"302","article-title":"Risk factors in gastric cancer","volume":"14","author":"Compare","year":"2010","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B9","first-page":"37","article-title":"Determination of Tubeimoside \u2160 in Jiazhongxiao preparation and serum of rat","volume":"15","author":"Cui","year":"2008","journal-title":"Chin. J. Info. Tradit. Chin. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1023\/a:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"607757","DOI":"10.3389\/fcell.2020.607757","article-title":"Tubeimoside I inhibits cell proliferation and induces a partly disrupted and cytoprotective autophagy through rapidly hyperactivation of MEK1\/2-ERK1\/2 Cascade via Promoting PTP1B in melanoma","volume":"8","author":"Du","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","article-title":"From traditional Chinese medicine to rational cancer therapy","volume":"13","author":"Efferth","year":"2007","journal-title":"Trends Mol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41419-018-1151-3","article-title":"Tubeimoside I induces accumulation of impaired autophagolysosome against cervical cancer cells by both initiating autophagy and inhibiting lysosomal function","volume":"9","author":"Feng","year":"2018","journal-title":"Cell Death Dis."},{"key":"B14","first-page":"49","article-title":"Pharmacological study on saponins of Bolbostemma paniculatum","volume":"1985","author":"Fu","year":"1985","journal-title":"Shaanxi Med. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbcan.2009.07.006","article-title":"Metastasis mechanisms","volume":"1796","author":"Geiger","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1871520619666181224121004","article-title":"Current perspectives in the application of medicinal plants against cancer: Novel therapeutic agents","volume":"19","author":"Gezici","year":"2019","journal-title":"Anticancer. Agents Med. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.18632\/oncotarget.6676","article-title":"Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model","volume":"7","author":"Gu","year":"2016","journal-title":"Oncotarget"},{"key":"B18","first-page":"12075","article-title":"Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway","volume":"8","author":"Hao","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bcp.2016.03.008","article-title":"Species differences in the pharmacokinetics of cefadroxil as determined in wildtype and humanized PepT1 mice","volume":"107","author":"Hu","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"B20","first-page":"11","article-title":"Effects of tubeimide-1 on cell cycle and apoptosis of human HL-60 myeloid leukemia","volume":"2003","author":"Hu","year":"2003","journal-title":"Chin. J. Clin. Oncol."},{"key":"B21","first-page":"58","article-title":"Determination of tubeimoside I, tubeimoside \u2161 and tubeimoside \u2162 in Bolbostemma paniculatum (maxim.) Franquet by HPLC","volume":"25","author":"Huang","year":"2016","journal-title":"China Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3892\/ijmm.2011.727","article-title":"Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway","volume":"28","author":"Huang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"14213","DOI":"10.1002\/jcb.28782","article-title":"Cancer drug resistance: A fleet to conquer","volume":"120","author":"Hussain","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/OTT.S76063","article-title":"Tubeimoside-1 induces glioma apoptosis through regulation of Bax\/Bcl-2 and the ROS\/Cytochrome C\/Caspase-3 pathway","volume":"8","author":"Jia","year":"2015","journal-title":"Onco. Targets. Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3969\/j.issn.1672-7770.2014.06.008","article-title":"Tubeimoside-1 induces apoptosis in human glioma U251 cell line by up-regulating FADD\/caspase-8\/caspase-3 pathway","volume":"11","author":"Jia","year":"2014","journal-title":"J. Clin. Neurosurg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.13241\/j.cnki.pmb.2016.03.004","article-title":"Tubeimoside-1 induces apoptosis in human glioma cell U251 through miR-21\/PDCD4 pathway","volume":"16","author":"Jia","year":"2016","journal-title":"Prog. Mod. Biomed."},{"key":"B27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s41401-018-0165-9","article-title":"Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway","volume":"40","author":"Jiang","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.drup.2014.12.002","article-title":"Host effects contributing to cancer therapy resistance","volume":"19","author":"Katz","year":"2015","journal-title":"Drug resist. updat."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.16438\/j.0513-4870.2020-1642","article-title":"Progress in antitumor activity of baicalin","volume":"56","author":"Kong","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1016\/j.bmcl.2015.07.053","article-title":"Cytotoxic triterpenoid glycosides (saikosaponins) from the roots of Bupleurum chinense","volume":"25","author":"Li","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.19540\/j.cnki.cjcmm.20210325.601","article-title":"Research progress on chemical constituents, pharmacological activities and clinical application of Bolbostemma paniculatum","volume":"46","author":"Li","year":"2021","journal-title":"China J. Chin. Mat. Med."},{"key":"B32","first-page":"270","article-title":"Study on targeting preparation of tubeimoside-1","volume":"2004","author":"Li","year":"2004","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3969\/j.issn.2095-140X.2016.11.015","article-title":"A study on tubeimoside-1 in inhibition of tumor angiogenesis in non-small-cell lung cancer xenograft rat models","volume":"28","author":"Li","year":"2016","journal-title":"Med. Pharm. J. Cpla."},{"key":"B34","first-page":"380","article-title":"Study on the preparation process of tubeimoside A-pulmonary targeting microspheres","volume":"2005","author":"Li","year":"2005","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B35","first-page":"1655","article-title":"Study on the in vitro release of a lung-targeted preparation of tebeimoside-1 for injection","volume":"30","author":"Li","year":"2009","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e4337","DOI":"10.1002\/bmc.4337","article-title":"A hybrid method for the determination of tubeimoside I in rat plasma after oral administration by LC-IT-TOF and UPLC-MS\/MS","volume":"32","author":"Li","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jchromb.2006.07.053","article-title":"Quantitative determination of the anticancer agent tubeimoside I in rat plasma by liquid chromatography coupled with mass spectrometry","volume":"845","author":"Liang","year":"2007","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"470452","DOI":"10.1155\/2014\/470452","article-title":"Research on the interaction between tubeimoside 1 and HepG2 cells using the microscopic imaging and fluorescent spectra method","volume":"2014","author":"Lin","year":"2014","journal-title":"Comput. Math. Methods Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbapap.2015.11.001","article-title":"TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53\/MDM2-dependent mechanism, a quantitative proteomics study","volume":"1864","author":"Lin","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B40","first-page":"14","article-title":"Effects of tubeimoside-1 on proliferation, apoptosis and autophagy of breast cancer MDA-MB-231 cells","volume":"59","author":"Liu","year":"2019","journal-title":"Shandong Med. J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3892\/mmr.2011.513","article-title":"Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780\/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways","volume":"4","author":"Liu","year":"","journal-title":"Mol. Med. Rep."},{"key":"B42","first-page":"695","article-title":"Tubeimoside-1 enhances chemosensitivity of drug-resistant ovarian cancer A2780\/DDP cells to cisplatin","volume":"33","author":"Liu","year":"","journal-title":"J. Third Mil. Med. Univ."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3892\/mmr.2016.4872","article-title":"Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9","volume":"13","author":"Liu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"B44","first-page":"119","article-title":"The effect of tubeimoside-1 on the activity of mitogen-activated protein kinase in human nasopharyngeal carcinoma epithelial cells","volume":"2007","author":"Liu","year":"2007","journal-title":"Beijing J. Tradit. Chin. Med."},{"key":"B45","first-page":"126","article-title":"Tubeimoside-1 induces apoptosis in human erythroleukemia cells K562","volume":"5","author":"Liu","year":"2006","journal-title":"J. Hangzhou Norm. Univ."},{"key":"B46","first-page":"171","article-title":"Significance and application of pharmacokinetics in drug development","volume":"2016","author":"Liu","year":"2016","journal-title":"Biotech. World."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3134","DOI":"10.1016\/j.apsb.2021.03.039","article-title":"Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8803","DOI":"10.1039\/c4ob01652a","article-title":"The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells","volume":"12","author":"Lorent","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"B49","first-page":"369","article-title":"Study on chromatography fingerprint and determination of Jibei Xiaozhong capsules","volume":"26","author":"Lu","year":"2015","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"key":"B50","first-page":"261","article-title":"Induction of cell cycle arrest and apoptosis by tubeimoside-1 isolated from Bolbostemma paniculatum in HeLa cells","volume":"9","author":"Ma","year":"2004","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.3390\/ijms21176102","article-title":"Nuclear p38: roles in physiological and pathological processes and regulation of nuclear translocation","volume":"21","author":"Maik-Rachline","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1194\/jlr.TR119000439","article-title":"Lipid rafts as signaling hubs in cancer cell survival\/death and invasion: implications in tumor progression and therapy","volume":"61","author":"Mollinedo","year":"2020","journal-title":"J. Lipid Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1093\/neuonc\/noab200","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2014\u20132018","volume":"23","author":"Ostrom","year":"2021","journal-title":"Neuro. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"502","DOI":"10.5483\/bmbrep.2016.49.9.030","article-title":"Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression","volume":"49","author":"Peng","year":"2016","journal-title":"BMB Rep."},{"key":"B55","first-page":"1111","article-title":"Quality standard of Shuangbei capsules","volume":"37","author":"Quan","year":"2018","journal-title":"Her. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"S51-S54","DOI":"10.1016\/j.jobcr.2016.07.003","article-title":"Salivary biomarkers in oral squamous cell carcinoma-An insight","volume":"6","author":"Radhika","year":"2016","journal-title":"J. Oral Biol. Craniofac. Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3329\/bjp.v7i3.11507","article-title":"Tubeimoside-1 inhibits growth via the induction of cell cycle arrest and apoptosis in human melanoma A375 cells","volume":"7","author":"Rasul","year":"2012","journal-title":"Bangladesh J. Pharmacol."},{"key":"B58","first-page":"761","article-title":"Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone","volume":"21","author":"Richert","year":"2009","journal-title":"Oncol. Rep."},{"key":"B59","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/ol.2020.11604","article-title":"Tubeimoside I induces autophagy in HepG2 cells by activating the AMP-activated protein kinase signaling pathway","volume":"20","author":"Ruan","year":"2020","journal-title":"Oncol. Lett."},{"key":"B60","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.phytochem.2017.11.007","article-title":"Triterpenoidal saponins from the fruits of Gleditsia caspica with proapoptotic properties","volume":"145","author":"Shaheen","year":"2018","journal-title":"Phytochemistry"},{"key":"B61","first-page":"315","article-title":"Simultaneous determination of nine components in uzengning capsules by HPLC wavelength switching method. West China J","volume":"33","author":"Sheng","year":"2018","journal-title":"Pharm. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.3892\/ol.2018.9051","article-title":"Tubeimoside-1 inhibits the proliferation and metastasis by promoting miR-126-5p expression in non-small cell lung cancer cells","volume":"16","author":"Shi","year":"","journal-title":"Oncol. Lett."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.3892\/mmr.2018.8459","article-title":"Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A\/VEGFR-2\/ERK signaling pathway","volume":"17","author":"Shi","year":"","journal-title":"Mol. Med. Rep."},{"key":"B64","first-page":"95","article-title":"Effect of tubeimoside-1 on proliferation and apoptosis of human lung adenocarcinoma cells","volume":"26","author":"Su","year":"2021","journal-title":"J. Clin. Pulm. Med."},{"key":"B65","first-page":"817","article-title":"Study on the liver-targeted drug delivery system of anticancer active ingredients from Bolbostemma paniculatum","volume":"30","author":"Sun","year":"2005","journal-title":"China J. Chin. Mat. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tox.2011.01.003","article-title":"Comparative pharmacokinetics of perfluorononanoic acid in rat and mouse","volume":"281","author":"Tatum-Gibbs","year":"2011","journal-title":"Toxicology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.omtn.2020.04.014","article-title":"Overexpression of microRNA-203 suppresses proliferation, invasion, and migration while accelerating apoptosis of CSCC cell line SCL-1","volume":"21","author":"Ting","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B68","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nri3902","article-title":"Immunological hallmarks of stromal cells in the tumour microenvironment","volume":"15","author":"Turley","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B69","first-page":"764","article-title":"Inhibitory effect of tebeimoside-1 on the metastasis of B16 melanoma and Lewis lung cancer in mice","volume":"11","author":"Wang","year":"","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"B70","first-page":"1935","article-title":"[Role of mitochondria in Tubeimoside I-mediated apoptosis in human cervical carcinoma HeLa cell line].","volume":"30","author":"Wang","year":"2005","journal-title":"China J. Chin. Mat. Med."},{"key":"B71","first-page":"679","article-title":"[Tubeimoside I-induced ultrastructural changes of human cervical carcinoma HeLa cell line and the protective effect of cyclosporine A].","volume":"27","author":"Wang","year":"2007","journal-title":"J. South. Med. Univ."},{"key":"B72","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00280-005-0047-y","article-title":"Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line","volume":"57","author":"Wang","year":"","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B73","first-page":"90","article-title":"Tubeimoside-1 affects the phenotype of skin squamous cell carcinoma SCL-1 cells by regulating the circ_0000376\/miR-203 axis","volume":"28","author":"Wang","year":"","journal-title":"J. Diagn. Ther. Dermato-VE."},{"key":"B74","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41419-020-02915-x","article-title":"Tubeimoside I-induced lung cancer cell death and the underlying crosstalk between lysosomes and mitochondria","volume":"11","author":"Wang","year":"","journal-title":"Cell Death Dis."},{"key":"B75","first-page":"2509","article-title":"Effect of tubeimoside-1 on proliferation and morphological of androgen-independent prostate cancer PC3 cells","volume":"24","author":"Wang","year":"2016","journal-title":"J. Mod. Oncol."},{"key":"B76","first-page":"3600","article-title":"Molecular effect of tubeimoside-1 on reversing drug resistance of A549\/DDP cell line","volume":"39","author":"Wang","year":"","journal-title":"Genomics Appl. Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"713","DOI":"10.3892\/mmr.2011.483","article-title":"Natural plant extract tubeimoside I induces cytotoxicity via the mitochondrial pathway in human normal liver cells","volume":"4","author":"Wang","year":"","journal-title":"Mol. Med. Rep."},{"key":"B78","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1248\/bpb.34.831","article-title":"Natural plant extract tubeimoside I promotes apoptosis-mediated cell death in cultured human hepatoma (HepG2) cells","volume":"34","author":"Wang","year":"","journal-title":"Biol. Pharm. Bull."},{"key":"B79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-2885.2007.00865.x","article-title":"Absorption, distribution, metabolism and excretion of tubeimoside-1 in animals","volume":"30","author":"Wang","year":"1994","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"B80","first-page":"52","article-title":"Preclinical pharmacological study of anti-cancer active ingredient crystalline D from Bolbostemma paniculatum","volume":"13","author":"Wang","year":"1984","journal-title":"Shaanxi Med. J."},{"key":"B81","first-page":"1652","article-title":"Research progress on anti-tumor mechanism of tubeimoside-1","volume":"42","author":"Wang","year":"","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/jps.24236","article-title":"Using improved serial blood sampling method of mice to study pharmacokinetics and drug-drug interaction","volume":"104","author":"Watanabe","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B83","first-page":"806","article-title":"[Apoptosis of human nasopharyngeal carcinoma CNE-2Z cells induced by tubeimoside I].","volume":"22","author":"Weng","year":"2003","journal-title":"Chin. J. Cancer."},{"key":"B84","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.2147\/OTT.S164503","article-title":"The effect of tubeimoside-1 on the proliferation, metastasis and apoptosis of oral squamous cell carcinoma in vitro","volume":"11","author":"Wu","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/jphp.13143","article-title":"Chrysophanol: A review of its pharmacology, toxicity and pharmacokinetics","volume":"71","author":"Xie","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1021\/pr801001j","article-title":"Tubeimoside-1 exerts cytotoxicity in HeLa cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways","volume":"8","author":"Xu","year":"2009","journal-title":"J. Proteome Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jprot.2011.08.014","article-title":"Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells","volume":"75","author":"Xu","year":"2011","journal-title":"J. Proteomics"},{"key":"B88","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3978\/j.issn.1000-9604.2013.06.03","article-title":"Intrinsic apoptotic pathway and G2\/M cell cycle arrest involved in tubeimoside I-induced EC109 cell death","volume":"25","author":"Xu","year":"2013","journal-title":"Chin. J. Cancer Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-2006-959459","article-title":"Potent anti-tumor activity and low toxicity of tubeimoside 1 isolated from Bolbostemma paniculatum","volume":"60","author":"Yu","year":"","journal-title":"Planta Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s00109-010-0669-3","article-title":"Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor","volume":"88","author":"Yadav","year":"2010","journal-title":"J. Mol. Med."},{"key":"B91","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13046-019-1355-0","article-title":"Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation","volume":"38","author":"Yan","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/aps.2016.34","article-title":"Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0\/G1 phase arrest in human prostate carcinoma cells in vitro","volume":"37","author":"Yang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1016\/j.fct.2011.10.001","article-title":"NF-\u03baB, JNK and p53 pathways are involved in tubeimoside-1-induced apoptosis in HepG2 cells with oxidative stress and G\u2082\/M cell cycle arrest","volume":"49","author":"Yin","year":"2011","journal-title":"Food Chem. Toxicol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.gene.2015.09.030","article-title":"p38 MAP kinases in the heart","volume":"575","author":"Yokota","year":"2016","journal-title":"Gene"},{"key":"B95","first-page":"103","article-title":"Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro","volume":"15","author":"Yu","year":"","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"B96","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3724\/SP.J1009.2008.00135","article-title":"The effect of tebeimoside-1 on the adhesion, invasion and migration of human highly metastatic giant cell lung cancer PGCL3 cells","volume":"16","author":"Yu","year":"2008","journal-title":"Chin. J. Nat. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-2006-957831","article-title":"Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by Tubeimoside 1","volume":"62","author":"Yu","year":"1996","journal-title":"Planta Med."},{"key":"B98","first-page":"3833","article-title":"The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases","volume":"63","author":"Zeelenberg","year":"2003","journal-title":"Cancer Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3971\/j.issn.1000-8578.2022.21.0768","article-title":"Recent advances in tumor therapy targeting FGFR","volume":"49","author":"Zhang","year":"2022","journal-title":"Cancer Res. Prev. Treat."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3969\/j.issn.1672-4992.2010.10.09","article-title":"Study on the inhibitory effect of cisplatin combined with tubeimoside-1 on the proliferation of cervical cancer Hela cells","volume":"18","author":"Zhang","year":"2010","journal-title":"J. Mod. Oncol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3892\/mmr.2010.379","article-title":"Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells","volume":"4","author":"Zhang","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"B102","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3892\/ol.2013.1117","article-title":"Effects of tubeimoside-1 on the proliferation and apoptosis of BGC823 gastric cancer cells in vitro","volume":"5","author":"Zhang","year":"2013","journal-title":"Oncol. Lett."},{"key":"B103","doi-asserted-by":"publisher","first-page":"705","DOI":"10.16548\/j.2095-3720.2016.09.003","article-title":"Inhibitory effects of tubeimoside-1 on the migration and invasion of human hepatoma (HepG2) cells","volume":"25","author":"Zhong","year":"2016","journal-title":"J. Logist. Univ. PAP."},{"key":"B104","doi-asserted-by":"publisher","first-page":"231","DOI":"10.12007\/j.issn.0258\u20104646.2022.03.008","article-title":"Construction of a transportation factor E2F1 regulatory network based on bioinformatics analysis","volume":"51","author":"Zhu","year":"2022","journal-title":"J. China Med. Univ."},{"key":"B105","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3969\/j.issn.1674-1749.2018.06.024","article-title":"Explore the source of medicinal use of traditional Chinese medicine Bolbostemma paniculatum from the perspective of literature","volume":"11","author":"Zhu","year":"2018","journal-title":"Glob. Tradit. Chin. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.941270\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T11:49:38Z","timestamp":1657885778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.941270\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,15]]},"references-count":105,"alternative-id":["10.3389\/fphar.2022.941270"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.941270","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,15]]},"article-number":"941270"}}